Compare GlobalFoundries Inc. Ordinary Shares (GFS) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GlobalFoundries Inc. Ordinary Shares vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? GlobalFoundries Inc. Ordinary Shares trades at $47.66 (market cap $27.51B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.8 (market cap $6.04B). The key difference: GlobalFoundries Inc. Ordinary Shares is far larger — about 4.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and GlobalFoundries Inc. Ordinary Shares pays a 0.97% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GlobalFoundries Inc. Ordinary Shares for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| GFS | IOVA | |
|---|---|---|
Market Cap | $27.51B | $6.04B |
Volume | 10,416,572 | 14,805,993 |
Sector | Technology | Health |
52-Week High | $89.96 | $14.82 |
52-Week Low | $32.24 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $26.80B | $5.97B |
Dividend Yield | 0.97% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GlobalFoundries Inc. Ordinary Shares
GlobalFoundries is a semiconductor foundry that manufactures chips for other companies. Its technologies serve automotive, communications, industrial, and consumer markets.
Read more on GFS →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
